Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Surgery Partners (SGRY) Preferred Dividend Payments (2018 - 2021)

Surgery Partners (SGRY) has disclosed Preferred Dividend Payments for 4 consecutive years, with $10.3 million as the latest value for Q1 2021.

  • Quarterly Preferred Dividend Payments rose 8.42% to $10.3 million in Q1 2021 from the year-ago period, while the trailing twelve-month figure was $10.3 million through Dec 2021, down 73.92% year-over-year, with the annual reading at $10.3 million for FY2021, 73.92% down from the prior year.
  • Preferred Dividend Payments hit $10.3 million in Q1 2021 for Surgery Partners, roughly flat from $10.3 million in the prior quarter.
  • In the past five years, Preferred Dividend Payments ranged from a high of $32.4 million in Q4 2018 to a low of $7.8 million in Q1 2018.
  • Historically, Preferred Dividend Payments has averaged $10.9 million across 4 years, with a median of $9.3 million in 2019.
  • Biggest five-year swings in Preferred Dividend Payments: plummeted 71.3% in 2019 and later increased 11.76% in 2020.
  • Year by year, Preferred Dividend Payments stood at $32.4 million in 2018, then tumbled by 71.3% to $9.3 million in 2019, then increased by 10.75% to $10.3 million in 2020, then changed by 0.0% to $10.3 million in 2021.
  • Business Quant data shows Preferred Dividend Payments for SGRY at $10.3 million in Q1 2021, $10.3 million in Q4 2020, and $10.0 million in Q3 2020.